Brief: Aptose Biosciences And Crystalgenomics Announce Issuance Of European Patent For CG-806
27/09/2018 12:13
Sept 27 (Reuters) - CrystalGenomics Inc 083790.KQ :
* APTOSE BIOSCIENCES AND CRYSTALGENOMICS ANNOUNCE ISSUANCE
OF
EUROPEAN PATENT FOR CG-806
* APTOSE BIOSCIENCES INC - PATENT IS EXPECTED TO PROVIDE
PROTECTION UNTIL END OF 2033
Source text for Eikon: ID:nGNXMgzmM
Further company coverage: 083790.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting